Clinical Trial Update: Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy

View source ↗

Summary

Clinical trial aiming to translate single-cell vulnerability into novel biomarkers and therapeutic targets for amyotrophic lateral sclerosis using a liquid nerv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Peripheral Neuropathy

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: Amyotrophic Lateral Sclerosis (ALS), Peripheral Neuropathies | Status: RECRUITING